Skip to main content

Displaying 721 - 740 of 4527

Pfizer/Mylan, In the Matter of

Pharmaceutical companies Pfizer Inc. and Mylan N.V. have agreed to divest assets and abide by other conditions to settle Federal Trade Commission charges that the proposed combination of Upjohn Inc. and Mylan N.V. will harm current or future competition in ten generic drug markets. The FTC’s complaint alleges that the proposed combination would harm current U.S. competition in seven product markets by reducing the number of existing suppliers, and that it would harm future U.S. competition in three additional product markets. The proposed consent order requires divestitures in all 10 markets.

Type of Action
Administrative
Last Updated
FTC Matter/File Number
191 0182
Docket Number
C-4727
Case Status
Pending

FTC Publishes Annual Performance Report

Date
The Federal Trade Commission published its Fiscal Year 2020 Performance Report as required under the Government Performance and Results Modernization Act of 2010. The report documents the progress...

Procter & Gamble Co. and Billie, Inc., In the Matter of

The Federal Trade Commission filed an administrative complaint  and authorized a suit in federal court to block The Procter & Gamble Company’s proposed acquisition of Billie, Inc., a direct-to-consumer company that began selling women’s razors and body care products in November 2017. The complaint alleged that the proposed acquisition would allow P&G, the market-leading supplier of both women’s and men’s wet shave razors, to buy Billie, a newer but expanding maker of women’s razors, and thereby eliminate growing competition that benefits consumers. On Jan. 5, 2021, the parties announced that they terminated their agreement for P&G to acquire Billie.

Type of Action
Administrative
Last Updated
FTC Matter/File Number
2010042
Docket Number
9400
Case Status
Closed